| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10307486 | Schizophrenia Research | 2013 | 6 Pages |
Abstract
The literature search revealed the paucity of the data. Careful switching from polypharmacy to monotherapy seems feasible in a majority of patients with schizophrenia. Assertive interventions, rather than passive educational approaches alone, appear more effective in reducing antipsychotic polypharmacy.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Hideaki Tani, Hiroyuki Uchida, Takefumi Suzuki, Yasuo Fujii, Masaru Mimura,